Select Page
Event info
Date:11 May
Time:14:00 - 18:00
Venue:Medicon Village, Lund, Sweden
Contact person
Katrine Brems Olsen

Katrine Brems Olsen

Network & Event Manager

+45 2337 0040

MVA Microbiome Network meeting: Microbiome Innovation – navigating between food supplements and pharma

Together with SmiLe Incubator, we have the pleasure of inviting members of Medicon Valley Alliance to the next Microbiome Network Meeting on the 11th of May 2023 in Lund, Sweden.

The network meeting will focus on how to navigate the regulatory frameworks in the area of Live Biotherapeutic Products (LBPs) and Foods for Special Medical Purposes (FSMPs), as well as how to design clinical studies for different purposes within the microbiome field.

To kick off the program we are pleased to have an international keynote speaker to share his insights on navigating complex regulatory frameworks. For several years Dr. Gosálbez has shared his insight in the microbiome area as a speaker at conferences such as Pharmabiotics and Probiota and this will be the first time he speaks in Scandinavia. We are also looking forward to hearing from companies in the Medicon Valley region who will share their experiences of developing FSMPs and LBPs – from food supplements to pharma.

Date: Thursday, 11th of May, 2023
Time: 14:00 – 18:00
Venue: Medicon Village, Auditorium, Building Inspira, Scheelevägen 4, Lund, Sweden
Moderator: Malin Sjöö, COO, Mello, former Business Developer, SmiLe



14:00 Registration, coffee & networking
14:30 Welcome & introduction
Anette Steenberg, CEO, Medicon Valley Alliance
Ulrika Ringdahl, COO, SmiLe Incubator
14:40 Keynote on navigating the regulatory framework in the microbiome field
Dr. Luis Gosálbez, Managing Director, Sandwalk Bioventures
15:00 The need for quality standardization
Philippe Holt, Director Quality, Clinical Microbiomics
15:15 Microbiome Therapeutics: Challenges in Regulatory & Market Access
Shahram Lavasani, Founder & CEO, ImmuneBiotech
15:30 Networking with coffee & cake
16:00 Navigating between supplements and Pharma: Pre-clinical and clinical drug development
Nigel Titford, CEO, BioGaia Pharma
Kristine Koppelhus, Director Scientific & Public Affairs, BioGaia AB

16:25 Panel conversation with the company speakers
Moderated by Malin Sjöö
17:00 Protecting the microbiome
Louise Aagaard, Partner, European Patent Attorney, HØIBERG
17:10 Networking with wine & wraps
18:00 End of the day


Organized by Host
Sponsored by  
Høiberg logo